Britannia Pharmaceuticals

Britannia Pharmaceuticals Focuses on Developing Innovative Products for Chronic and Severe Diseases, Particularly Treatments for Parkinson's Disease. For Over 30 Years, Britannia's Main Area of Interest Has Been the Development of Patient-Centered Innovative Technologies to Effectively Provide Treatment for Patients with Parkinson's Disease.